Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07 September 2023 - 7:57PM
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX:
TH) (NASDAQ: THTX), a biopharmaceutical company focused on the
development and commercialization of innovative therapies, today
announced that Paul Lévesque, President and Chief Executive
Officer, will present at the H.C. Wainwright 25th Annual Global
Investment Conference, to be held virtually and in person on
September 11-13, 2023, in New York City at the Lotte New York
Palace Hotel.
Once the presentation becomes available on demand, registered
attendees can submit their questions for the Company.
Theratechnologies will also be available for 1x1 investor meetings,
in-person and virtually on Monday September 11. Further information
on the conference can be found here.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a
biopharmaceutical company focused on the development and
commercialization of innovative therapies addressing unmet medical
needs. Further information about Theratechnologies is available on
the Company's website at www.theratech.com , on SEDAR at
www.sedarplus.ca and on EDGAR at www.sec.gov. Follow
Theratechnologies on Linkedin and Twitter.
Contacts:
Investor Inquiries:Philippe DubucSenior Vice President and Chief
Financial Officerpdubuc@theratech.com 438-315-6608
Theratechnologies (TSX:TH)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Theratechnologies (TSX:TH)
Historical Stock Chart
Von Mai 2023 bis Mai 2024